Journal of Clinical Oncology, 36(10), 942-950. American Society of Clinical Oncology Roemer, M G M, Redd, R A, Cader, F Z, Pak, C J, Abdelrahman, S, Ouyang, J, Sasse, S, Younes, A, Fanale, M, Santoro, A, Zinzani, P L, Timmerman, J, Collins, G P, Ramchandren, R, Cohen, J B, de Boer, J P, Kuruvilla, J, Savage, K J, Trneny, M, Ansell, S, Kato, K, Farsaci, B, Sumbul, A, Armand, P, Neuberg, D S, Pinkus, G S, Ligon, A H, Rodig, S J & Shipp, M A 2018, ' Major histocompatibility complex class II and programmed death ligand 1 expression predict outcome after programmed death 1 blockade in classic Hodgkin lymphoma ', Journal of Clinical Oncology, vol. 36, no. 10, pp. 942-950 . https://doi.org/10.1200/JCO.2017.77.3994
Baris, Hagit N, Wai-Man Chan, Caroline Andrews, Doron M Behar, Diana J Donovan, Cynthia C Morton, Judith Ranells, Tuya Pal, Azra H Ligon, and Elizabeth C Engle. 2013. “Complex cytogenetic rearrangements at the DURS1 locus in syndromic Duane retraction syndrome.” Clinical Case Reports 1 (1): 30-37. doi:10.1002/ccr3.11. http://dx.doi.org/10.1002/ccr3.11.